Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 5 , Pages 473-479 , September 2010

The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancers

  • Hervé Wallerand, M.D., Ph.D.

      Affiliations

    • Department of Urology, Centre Hospitalo-Universitaire Pellegrin-Tripode, Victor Segalen School of Medicine, Bordeaux, France
    • Corresponding Author InformationCorresponding author. Tel.: +33-5-5679 5535; fax: +33-5-5679 5651
    • ,
  • Grégoire Robert, M.D.

      Affiliations

    • Department of Urology, Centre Hospitalo-Universitaire Pellegrin-Tripode, Victor Segalen School of Medicine, Bordeaux, France
    • ,
  • Gilles Pasticier, M.D.

      Affiliations

    • Department of Urology, Centre Hospitalo-Universitaire Pellegrin-Tripode, Victor Segalen School of Medicine, Bordeaux, France
    • ,
  • Alain Ravaud, M.D., Ph.D.

      Affiliations

    • Department of Medical Oncology, Centre Hospitalo-Universitaire Saint-André, Victor Segalen School of Medicine, Bordeaux, France
    • ,
  • Philippe Ballanger, M.D.

      Affiliations

    • Department of Urology, Centre Hospitalo-Universitaire Pellegrin-Tripode, Victor Segalen School of Medicine, Bordeaux, France
    • ,
  • Robert E. Reiter, M.D.

      Affiliations

    • Department of Urology, Jonsson Comprehensive Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    • ,
  • Jean-Marie Ferrière, M.D.

      Affiliations

    • Department of Urology, Centre Hospitalo-Universitaire Pellegrin-Tripode, Victor Segalen School of Medicine, Bordeaux, France

Received 13 November 2008 ,Revised 17 December 2008 ,Accepted 18 December 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This work was supported by a grant from Ligue Nationale contre le Cancer (LNCC).

PII: S1078-1439(08)00389-X

doi: 10.1016/j.urolonc.2008.12.018

Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 5 , Pages 473-479 , September 2010

Article Tools

* Image Usage & Resolution